[Evidence summary]: What is the evidence on additional risk for people>65 with cardiovascular disease? [v2.0]
| dc.contributor.author | National Health Library & Knowledge Service (NHLKS) | |
| dc.contributor.author | Quinn, Emma | |
| dc.contributor.author | Leen, Brendan | |
| dc.contributor.author | Ryan, Pauline | |
| dc.date.accessioned | 2021-01-13T09:40:24Z | |
| dc.date.available | 2020-09-18T15:20:16Z | |
| dc.date.available | 2021-01-13T09:40:24Z | |
| dc.date.issued | 2021-01-12 | |
| dc.identifier.uri | http://hdl.handle.net/10147/628306 | |
| dc.description | Main Points 1. People >60 and those with underlying health conditions including hypertension, diabetes, cardiovascular disease, chronic respiratory disease, cancer andobesity have higher COVID-19 related morbidity and mortality. 2. COVID-19 may result in cardiovascular complications in patients without prior cardiovascular disease. 3. Several potential COVID‐19 therapies may also have cardiovascular consequences or may have significant drug-drug interactions with cardiovascular medications. 4. Routine and emergency cardiac care for patients who are, may be, or are not infected with COVID-19 may be delayed. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Health Service Executive | en_US |
| dc.relation.ispartofseries | Question 68 | en_US |
| dc.subject | CORONAVIRUS | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | OLDER PEOPLE | en_US |
| dc.subject | RISK FACTORS | en_US |
| dc.title | [Evidence summary]: What is the evidence on additional risk for people>65 with cardiovascular disease? [v2.0] | en_US |
| dc.type | Other | en_US |
| refterms.dateFOA | 2020-09-18T15:20:17Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics